MPTP alters central catecholamine neurons in addition to the nigrostriatal system

This publication has 15 references indexed in Scilit:

• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset
  Neuroscience Letters, 1984
• Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
  Science, 1984
• Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice
  Neuropharmacology, 1984
• Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP
  European Journal of Pharmacology, 1984
• The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and Man
  Canadian Journal of Neurological Sciences, 1984
• Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse
  European Journal of Pharmacology, 1984
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983
• Standardization of the sucrose-potassium phosphate-glyoxylic acid histofluorescence method for tissue monoamines
  Neuroscience Letters, 1980
• Chronic parkinsonism secondary to intravenous injection of meperidine analogues
  Psychiatry Research, 1979
• THE BRAIN-STEM LESIONS IN PARKINSONISM
  Journal of Neurology, Neurosurgery & Psychiatry, 1953